Health Press Release – Weekly Newsletter for March 1-1, 2010
Monday, March 1, 2010
Elsevier is Meeting Today’s Medical Students’ Needs With Online, Mobile and Print Tools
Company Celebrates Medical Education Innovation at AMSA's 60th Anniversary Convention
PHILADEPHIA, February 22, 2010 – Elsevier, the leading publisher of scientific, technical and medical
information, today announced it is celebrating medical education innovation
at the American Medical Student Association's (AMSA) 60th Annual Convention
(www.amsa.org/AMSA/Homepage/Events/Convention.aspx), March 11-14,
2010, at the Disneyland Hotel in Anaheim, California.
"Elsevier is [...]
Retacrit(TM) to be the 1st Biosimilar Epoetin to Achieve Subcutaneous Licence in Renal Patients
Retacrit(TM) Received a Positive Opinion From the European Committee for Medicinal Products for Human Use (CHMP) for Subcutaneous (SC) use in Renal Anaemia
LONDON, February 22, 2010 – Hospira announced today that the European Committee for Medicinal
Products for Human Use (CHMP) has recommended for approval the administration
of Retacrit (epoetin zeta) subcutaneously in the nephrology setting. [...]
ConvaTec Introduces Flexi-Seal(R)(TM) SIGNAL(TM) FMS
A new solution from the Flexi-Seal(R)(TM) FMS family of fecal management systems that helps clinicians seal their patients' protection
SKILLMAN, New Jersey, February 22, 2010 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, announced today the launch of
Flexi-Seal(R)(TM) SIGNAL(TM) Fecal Management System (FMS). Now available in
the U.S., U.K. [...]
Newton Gets 2 Years for World-First hGH Positive Finding
LONDON, February 22, 2010 – In a major breakthrough in the international fight against doping in
sport, UK Anti-Doping today announced the first case of human growth hormone
(hGH)* resulting in an athlete sanction.
Wakefield Trinity Wildcats player Terry Newton has accepted a 2-year
sanction for the presence of hGH in a blood sample [...]
Chiltern Announces Partnership With Charles River
LONDON, February 22, 2010 – Chiltern International Limited, a global contract research organization
(CRO), announced its latest collaboration with Charles River Laboratories,
Inc. As part of this collaboration, Chiltern Early Phase will partner with
Charles River to conduct and support early phase radiolabelled studies.
Glenn Kerkhof, Chiltern CEO, stated, "This new partnership is an [...]
Torchmark Corporation to Present at Bank of America Merrill Lynch Insurance Conference
MCKINNEY, Texas, February 22, 2010 – Torchmark Corporation (NYSE: TMK) announced today that its Chief
Executive Officer, Mark McAndrew, and Chief Financial Officer, Gary Coleman,
will present Tuesday, February 23, 2010 at the Bank of America Merrill Lynch
Insurance Conference in New York City. Torchmark's presentation is scheduled
to begin at 8:35 a.m. EST.
[...]
Amsterdam Molecular Therapeutics Reports Full Year Results 2009
AMSTERDAM, The Netherlands, February 24, 2010 – Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today reported its results for the year to
December 31, 2009.
Highlights
– Glybera(R) Marketing Authorisation Application submitted to
European Medicines Agency (EMA, formerly [...]
InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools
Students, Researchers can 'Walk Through' a Body; Virtual Reality Meets Anatomy, as Advanced Gaming Technology Brings Human Body to Life
PHILADELPHIA, February 23, 2010 – Elsevier, the world's leading content provider of science and
health information, today announced the availability of the InteractElsevier
(www.interactelsevier.com) Series. Powered by CyberAnatomy, an
Iowa-based company that creates interactive learning systems for students,
the [...]
Elsevier’s new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content
PHILADEPLHIA, Pennsylvania, February 23, 2010 – Elsevier, the world's leading publisher of scientific, technical and
medical (STM) information products and services announced today that it is
publicly sharing its internal custom publication guidelines so that the
scientific and medical communities can have insight into a new and practical
set of publishing standards for producing custom and sponsored publications.
The [...]
Charity SOS Children calls for “no UK deductions for Haiti”
CAMBRIDGE, England, February 23, 2010 – Orphan charity SOS Children UK is calling on all British NGOs
to pledge to make no UK deductions for Haiti – specifically to promise not to
use any donations or sponsorships given for Haiti in 2010 to pay for UK spend
on advertising, fundraising, admin, advocacy or anything else.
[...]
Ketchum and TBWA\RAAD\PR Create Joint Venture in Middle East; Firm Will be Known as Ketchum Raad Middle East
Two Premier Communications Networks Formalize Partnership, Combining Excellent Regional and Global Services and Capabilities
NEW YORK and DUBAI, February 23, 2010 – Ketchum, one of the world's leading public relations agencies, and
TBWA\RAAD\PR, the fast-growing communications network in the Middle East,
today announced the formation of a joint venture agreement to deliver
enhanced capabilities to clients in the [...]
International Rare Disease Day
"Patients and Researchers: Partners for Life!"
PARIS, February 24, 2010 – For this annual event hundreds of patient groups and their
partners organise activities to raise awareness on rare diseases and the 30
million people affected by them in Europe.
Rare Disease Day was launched and is coordinated by the
European Organisation for Rare Diseases [...]
Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
CAMBRIDGE, Massachusetts, February 24, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces it has received Fast Track designation
from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement
therapy for Fabry disease.
Shire filed a BLA for REPLAGAL in December 2009. The FDA requested
additional human pharmacokinetic data to [...]
First Awards Made by London Genetics’ Proof-of-Concept Fund
LONDON, February 24, 2010 – London Genetics Limited, an expert in the use of pharmacogenetics in
clinical drug discovery and development, has awarded the first three grants
from its proof-of-concept (POC) fund. The awards, to teams at Imperial
College London and University College London, are for research in the areas
of immunotherapy, schizophrenia and heart disease. Financial details [...]
Sanmina-SCI Tatabanya, Hungary Facility Achieves ISO 13485 Certification for Medical Devices
SAN JOSE, California, February 24, 2010 – Sanmina-SCI Corporation (Nasdaq: SANM), a leading global Electronics
Manufacturing Services (EMS) company, today announced that its Tatabanya,
Hungary facility has received ISO 13485 certification for medical device
manufacturing.
ISO 13485 is an internationally recognized standard developed to ensure
that companies provide medical devices that consistently meet regulatory
requirements. In [...]
IPO Prospects High on the Agenda at BioTrinity
Venue: Newbury Racecourse From Apr 12-14 2010
LONDON, February 24, 2010 – First Quarter of 2010 has shown some early signs of resurgence in life
science IPO's that are already underway or planned. BioTrinity, the UK's
Premier Biopartnering and Investment Conference, will be focusing on the
evidence for early success and the prospects for the remainder of the [...]
Star Scientific Files Application with FDA for Ariva-BDL(TM) Approval as First Modified Risk Tobacco Product
GLEN ALLEN, Virginia, February 24, 2010 – Star Scientific, Inc. (Nasdaq: CIGX) announced that on Friday, February
19 the company filed an application with the Food & Drug Administration for
approval to market Ariva-BDL(TM) as a "modified risk" tobacco product under
the Family Smoking Prevention and Tobacco Control Act of 2009. This
submission is the first such application [...]
Princess Haya Calls for Action to Protect Health in the Developing World
GENEVA, February 24, 2010 – Tobacco use encouraged by aggressive marketing and growing obesity linked
to poor diets and physical inactivity endanger millions of people in the
developing world, Princess Haya Al Hussein of Jordan said today at a
conference hosted by the World Health Organization (WHO).
In a keynote address at the Noncommunicable [...]
Next Generation Ultrasound: An Evolution in Diagnosis and Therapy – Upcoming Frost & Sullivan Web Conference
LONDON, February 25, 2010 – Exposure to radiation from imaging equipment is constantly subjected to
scrutiny from regulatory authorities. Ultrasound poses no radiation threat
and is constantly further developed to accentuate primary and secondary
diagnosis. The next wave in ultrasound technology will witness advancements
in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis. High
intensity focused ultrasound (HIFU) is [...]
Champagne Louis Roederer Gets ‘Loved Up’ at the Love Ball in Aid of The Naked Heart Foundation
LONDON, February 25, 2010 – Champagne Louis Roederer were delighted to sponsor the Love
Ball on Tuesday night at The Roundhouse, Camden. The event, hosted by
Supermodel Natalia Vodianova and Lucy Yeomans, Editor of Harper's Bazaar UK,
also included an auction to raise funds for The Naked Heart Foundation, a
charity that builds play facilities for underprivileged children [...]
OBN Launches Unique Group Private Medical Insurance Scheme for Life Sciences Companies
OXFORD, England, February 25, 2010 – Oxfordshire Bioscience Network Ltd ("OBN"), the Oxford based
not-for-profit biotech trade association is pleased to announce that they
have secured a deal with BUPA which will allow the employees of their member
companies to receive highly competitive private medical insurance (PMI)
within a unique group scheme. The deal comes about as a [...]
Seatrans AS Increases Safeguards for Crew Members
Concateno Selected to Support Crew Welfare With New Benzene Monitoring Test
BERGEN, Norway and LONDON, February 25, 2010 – Concateno, Europe's most experienced chemical, drug and
alcohol testing provider with 20 years' experience in the maritime industry,
has been selected by Norwegian shipping company, Seatrans AS, to monitor the
potential exposure of its seafaring crew to benzene.
[...]
DPP Issues New Guidance on Assisted Suicide
LONDON, February 25, 2010 – The Director of Public Prosecutions (DPP) has launched new
guidance today on assisted suicide.
Their publication follows a successful campaign led by Debbie
Purdy, who has MS, on the issue of clarification around assisted suicide.
Jayne Spink, Director of Policy & Research at the MS [...]
WORLD PISTACHIO DAY: A Global Chance to Celebrate the Wonderful Green Nut
LOS ANGELES, February 25, 2010 – February 26th is World Pistachio Day, so why not take a moment to reflect
on the amazing history and modern day health benefits of this wonderful nut?
Pistachios contain only 3-4 calories per nut, and offer more than 30
different vitamins, minerals and beneficial phytonutrients making them [...]